Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713886 | SCV000844526 | uncertain significance | not provided | 2017-10-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003768113 | SCV004693929 | uncertain significance | Charcot-Marie-Tooth disease axonal type 2C | 2023-07-28 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TRPV4 protein function. ClinVar contains an entry for this variant (Variation ID: 586844). This variant has not been reported in the literature in individuals affected with TRPV4-related conditions. This variant is present in population databases (rs759859968, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 248 of the TRPV4 protein (p.Arg248His). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000713886 | SCV005369736 | uncertain significance | not provided | 2023-06-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |